---
figid: PMC7333809__bcr-2019-233842f02
figtitle: Atezolizumab-induced type 1 diabetes mellitus in a patient with metastatic
  renal cell carcinoma
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7333809
filename: bcr-2019-233842f02.jpg
figlink: /pmc/articles/PMC7333809/figure/F2/
number: F2
caption: Programmed cell death-ligand 1 (PD-L-1) pathway. (A) Upregulation of programmed
  cell death protein 1 (PD-1) pathway leads to increased inhibition of T cell/ immune
  response. (B) Inhibition of the PD-1 pathway via anti-PD-L1 leads to upregulation
  of immune response. MHC, major histocompatibility complex; TCR, T cell receptor.
papertitle: Atezolizumab-induced type 1 diabetes mellitus in a patient with metastatic
  renal cell carcinoma.
reftext: Wedad Rahman, et al. BMJ Case Rep. 2020;13(7):e233842.
year: '2020'
doi: 10.1136/bcr-2019-233842
journal_title: BMJ Case Reports
journal_nlm_ta: BMJ Case Rep
publisher_name: BMJ Publishing Group
keywords: diabetes | chemotherapy
automl_pathway: 0.9378665
figid_alias: PMC7333809__F2
figtype: Figure
redirect_from: /figures/PMC7333809__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7333809__bcr-2019-233842f02.html
  '@type': Dataset
  description: Programmed cell death-ligand 1 (PD-L-1) pathway. (A) Upregulation of
    programmed cell death protein 1 (PD-1) pathway leads to increased inhibition of
    T cell/ immune response. (B) Inhibition of the PD-1 pathway via anti-PD-L1 leads
    to upregulation of immune response. MHC, major histocompatibility complex; TCR,
    T cell receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HLA-C
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - Mhc
  - zip
  - Tcr
  - beta-Spec
  - betaTub56D
  - betaTry
  - anon-70Da
---
